. Cerebrospinal fluid amyloid beta42/phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia. J Gerontol A Biol Sci Med Sci. 2006 Jul;61(7):755-8. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ1-42
(CSF)
AD
(61)
419 ± 128
ng/mL
ELISA;
Innotest;
Innogenetics
McKhann et al., 1984
Aβ1-42
(CSF)
CTRL-
Other Controls
(30)
869 ± 207
ng/mL
ELISA;
Innotest;
Innogenetics
tau-p181
(CSF)
AD
(61)
103 ± 44
ng/mL
ELISA;
Innotest;
Innogenetics
McKhann et al., 1984
tau-p181
(CSF)
CTRL-
Other Controls
(30)
53 ± 16
ng/mL
ELISA;
Innotest;
Innogenetics
tau-total
(CSF)
AD
(61)
613 ± 326
ng/mL
ELISA;
Innotest;
Innogenetics
McKhann et al., 1984
tau-total
(CSF)
CTRL-
Other Controls
(30)
184 ± 89
ng/mL
ELISA;
Innotest;
Innogenetics

Recommends

Please login to recommend the paper.

Comments

Comments on this Paper

No Available Comments

Make a Comment

To make a comment you must login or register.